Similar Articles
181 Association of preoperative antiviral treatment with incidences of post-hepatectomy liver failure in hepatitis B virus-related hepatocellular carcinoma
182 Liver stiffness in hepatocellular carcinoma and chronic hepatitis patients: Hepatitis B virus infection and transaminases should be considered
183 Oncolytic virotherapy for hepatocellular carcinoma: A potent immunotherapeutic landscape
184 Effectiveness of transarterial chemoembolization in combination with lenvatinib and programmed cell death protein-1 inhibition for unresectable hepatocellular carcinoma
185 Maximizing therapeutic outcomes in hepatocellular carcinoma: Insights into combinatorial strategies
186 Effectiveness and safety of sequential transarterial chemoembolization and microwave ablation for subphrenic hepatocellular carcinoma: A comprehensive evaluation
187 Prognostic significance of exportin-5 in hepatocellular carcinoma
188 BCAR3 and BCAR3-related competing endogenous RNA expression in hepatocellular carcinoma and their prognostic value
189 Immune effect and prognosis of transcatheter arterial chemoembolization and tyrosine kinase inhibitors therapy in patients with hepatocellular carcinoma
190 Clinical benefits of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors for unresectable hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA